CMS mandates registry data for coverage of Alzheimer’s drugs
CMS announced that it will cover Eisai's Leqembi, upon a traditional approval, if physicians enter patient data into registries.
Novartis touts breast cancer win with “landmark” Kisqali results
AstraZeneca and MSD’s Lynparza combo bags FDA approval for prostate cancer
After US approval, Amylyx faces regulatory hurdle in Europe for ALS treatment
Pneumagen raises £8 million for further study of intranasal antiviral
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreXtalPi announces $250m AI drug discovery collaboration with Eli Lilly
XtalPi brings together AI “dry lab” algorithms and “wet lab” robotics to drive innovation.
More themes
Insights
View MoreWho’s investing where? Private equity deal activity in the pharmaceutical industry in Europe decreased by 29% in Q1 2023
In the European pharmaceutical industry, there were 15 private equity deals announced in Q1 2023, worth a total value of…
University of Sydney will use AI to boost cancer drug research
SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine
Medsenic amends licence agreement with Phebra for arsenic trioxide
Novavax receives positive opinion from CHMP for full MA of Covid vaccine